Futura Medical plc Stock
Stocks
FUM
GB0033278473
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
19:35:25 23/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1600 GBX | -11.11% |
|
-13.04% | -85.65% |
| 10-20 | Futura Medical plc Announces Termination of Gordon Roy Davis as Director, Effective October 20, 2026 | CI |
| 10-12 | Arkle finds uranium; hVIVO poaches CFO from Futura | AN |
| Market Cap | 2.37M 3.17M 2.83M 2.62M 4.44M 301M 4.51M 31.49M 12.47M 158M 11.91M 11.65M 497M | P/E 2024 |
77.2x | P/E 2025 | -0.4x |
|---|---|---|---|---|---|
| Enterprise Value | -1.03M -1.38M -1.23M -1.14M -1.93M -131M -1.96M -13.68M -5.41M -68.52M -5.17M -5.06M -216M | EV / Sales 2024 |
6,428,637x | EV / Sales 2025 | 1,815,433x |
| Free-Float |
55.74% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| FUM | Delayed | |
CBOE
| FUM | Real-time | |
|
OTC Markets
| FAMDF | Delayed | |
|
Börse Stuttgart
| GYX | Delayed | |
|
Deutsche Boerse AG
| GYX | Delayed | |
|
Boerse Muenchen
| GYX | Real-time |
Last Transcript: Futura Medical plc
| 1 day | -11.11% | ||
| 1 week | -13.04% | ||
| Current month | -18.78% | ||
| 1 month | -18.37% | ||
| 3 months | -60.00% | ||
| 6 months | -88.97% | ||
| Current year | -85.65% |
| 1 week | 0.16 |  | 0.21 |
| 1 month | 0.16 | | 0.26 |
| Current year | 0.16 | | 1.75 |
| 1 year | 0.16 | | 3.09 |
| 3 years | 0.16 | | 47.8 |
| 5 years | 0.16 | | 67 |
| 10 years | 0.16 | | 84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Duggan
CEO | Chief Executive Officer | 56 | 08/08/2025 |
| Director of Finance/CFO | 61 | 12/10/2026 | |
Ken James
CTO | Chief Tech/Sci/R&D Officer | 74 | 16/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ken James
BRD | Director/Board Member | 74 | 01/04/2016 |
Andrew Unitt
CHM | Chairman | 69 | - |
Alexander Duggan
BRD | Director/Board Member | 56 | 08/08/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/12/25 | Buy | Chief Financial Officer | 500,000 | 0.1488% | ||
| 08/12/25 | Buy | Chief Executive Officer | 5,000,000 | 1.4876% | ||
| 08/12/25 | Buy | Chief Technology Officer | 500,000 | 0.1488% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -11.11% | -13.04% | -94.40% | -99.53% | 3.17M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | -0.86% | +0.87% | +33.83% | +116.85% | 38.31B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.02% | +142.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.93 18.63 16.63 15.37 26.05 1.77K 26.48 184.92 73.21 926.48 69.91 68.42 2.92K | 1.7 2.27 2.03 1.87 3.17 215.44 3.23 22.53 8.92 112.88 8.52 8.34 355.87 |
| Net income | 1.29M 1.73M 1.54M 1.43M 2.42M 164M 2.46M 17.17M 6.8M 86.02M 6.49M 6.35M 271M | -9.07M -12.13M -10.83M -10.01M -16.97M -1.15B -17.25M -120M -47.69M -603M -45.53M -44.57M -1.9B |
| Net Debt | -6.6M -8.82M -7.88M -7.28M -12.34M -838M -12.54M -87.59M -34.68M -439M -33.11M -32.41M -1.38B | -3.4M -4.55M -4.06M -3.75M -6.36M -432M -6.47M -45.17M -17.88M -226M -17.08M -16.71M -713M |
Employees
13
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | GBX 0.1600 | -11.11% | 18,758,670 |
| 22/10/26 | GBX 0.1800 | +5.88% | 6,155,511 |
| 21/10/26 | GBX 0.1700 | -5.56% | 21,605,402 |
| 20/10/26 | GBX 0.1800 | -9.55% | 4,861,477 |
| 19/10/26 | GBX 0.1990 | +8.15% | 9,535,612 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- FUM Stock
Select your edition
All financial news and data tailored to specific country editions
